Ranbaxy forfeits 180 days exclusivity for generic Nexium

Ranbaxy said USFDA has determined that it has forfeited its 180-day exclusivity to sell generic version of digestive disorder medicine Nexium in US market
Source: The Economic Times Healthcare and Biotech News - Category: Pharmaceuticals Source Type: news